ABC | Volume 111, Nº2, Agosto 2018

Diretrizes 3ª Diretriz Brasileira de Transplante Cardíaco Arq Bras Cardiol. 2018; 111(2):230-289 162. Tydén G, Ekberg H, Tufveson G, Mjörnstedt L. A randomized, double- blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up. Transplantation. 2012; 94(3):e21-2. doi: 10.1097/01.tp.0000418580.88642.e1. 163. Ejaz NS, Shields AR, Alloway RR, Sadaka B, Girnita AL, Mogilishetty G, et al. Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipients. Am J Transplant. 2013;13(12):3142-54. doi: 10.1111/ajt.12493. 164. O'Leary JG, Samaniego M, Barrio MC, Potena L, Zeevi A, Djamali A, et al. The influence of immunosuppressive agents on the risk of De Novo donor-specific HLA antibody production in solid organ transplant recipients. Transplantation. 2016;100(1):39-53. doi: 10.1097/ TP.0000000000000869. 165. Delgado JC, Fuller A, Ozawa M, Smith L, Terasaki PI, Shihab FS, et al. No occurrence of de novoHLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study. Transplantation. 2009;87(4):546-8. doi: 10.1097/TP.0b013e3181949d2e. 166. Cole RM, Kobashigawa JA. Desensitization strategies pre- and post-cardiac transplantation. Curr Treat Options Cardiovasc Med. 2016;18(2):8. doi: 10.1007/s11936-015-0431-9. 167. Fredrich R, Toyoda M, Czer L, Galfayan K, Galera O, Trento A, et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation. 1999;67(3):385-91. PMID: 10030283. 168. Jurcevic S, Ainsworth ME, Pomerance A, Smith JD, Robinson DR, Dunn MJ, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation. 2001;71(7):886-92. PMID: 11349721. 169. Suárez-Alvarez B, López-Vázquez A, Gonzalez MZ, Fdez-Morera JL, Díaz-Molina B, Blanco-Gelaz MA, et al. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection. Am J Transplant. 2007;7(7):1842-8. doi: 10.1111/j.1600-6143.2007.01838.x. 170. Barz D, Friedrich S, Schuller A, Rummler S. Antibodies against AT1-receptor in transplantation (diagnostics, treatment, clinical relevance). Atheroscler Suppl. 2015 May;18:112-8. doi: 10.1016/j. atherosclerosissup.2015.02.021 171. Colvin MM, Cook JL, Chang P, Francis G, Hsu DT, Kiernan MS, et al; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiopulmonary Critical Care, Perioperative and Resuscitation; American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Disease in the Young; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing; American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Radiology and Intervention; American Heart Association Heart Failure and Transplantation Committee of the Council on Cardiovascular Surgery and Anesthesia. Antibody- mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2015;131(18):1608-39. doi: 10.1161/ CIR.0000000000000093. 172. Berry GJ, Burke MM, Andersen C, Bruneval P, Fedrigo M, Fishbein MC, et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2013;32(12):1147-62. doi: 10.1016/j.healun.2013.08.011. 173. Ibrahim M, Hendry P, Masters R, Rubens F, Lam BK, Ruel M, et al. Management of acute severe perioperative failure of cardiac allografts: a single-centre experience with a review of the literature. Can J Cardiol. 2007;23(5):363-7. PMID: 17440641. 174. Crudele V, Picascia A, Infante T, Grimaldi V, Maiello C, Napoli C. Repeated immune and non immune insults to the graft after heart transplantation. Immunol Lett. 2011;141(1):18-27. doi: 10.1016/j. imlet.2011.07.004. 175. Kaczorowski DJ, Datta J, Kamoun M, Dries DL, Woo YJ. Profound hyperacutecardiacallograftrejectionrescuewithbiventricularmechanical circulatorysupportandplasmapheresis, intravenous immunoglobulin,and rituximab therapy. J Cardiothorac Surg. 2013;8:48. doi: 10.1186/1749- 8090-8-48. 176. Kittleson MM. Changing role of heart transplantation. Heart Fail Clin. 2016;12(3):411-21. doi: 10.1016/j.hfc.2016.03.004. 177. Patel JK, KittlesonM, Kobashigawa JA. Cardiac allograft rejection. Surgeon. 2011;9(3):160-7. doi: 10.1016/j.surge.2010.11.023. 178. Mingo-Santos S, Moñivas-Palomero V, Garcia-Lunar I, Mitroi CD, Goirigolzarri-Artaza J, Rivero B, et al. Usefulness of Two-Dimensional Strain Parameters toDiagnose Acute Rejection after Heart Transplantation. J Am Soc Echocardiogr. 2015;28(10):1149-56. doi: 10.1016/j. echo.2015.06.005. 179. Şimşek E, Nalbantgil S, Ceylan N, Zoghi M, Kemal HS, Engin Ç, et al. Diagnostic performance of late gadolinium enhancement in the assessment of acute cellular rejection after heart transplantation. Anatol J Cardiol. 2016;16(2):113-8. doi: 10.5152/AnatolJCardiol.2015.5961. 180. Labarrere CA, Jaeger BR. Biomarkers of heart transplant rejection: the good, the bad, and the ugly. Transl Res. 2012;159(4):238-51. doi: 10.1016/j.trsl.2012.01.018. 181. Fang K. Clinical utilities of peripheral blood gene expression profiling in the management of cardiac transplant patients. J Immunotoxicol. 2007;4(3):209-17. doi: 10.1080/15476910701385570. 182. Stewart S, Winters GL, FishbeinMC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24(11):1710-20. doi: 10.1016/j.healun.2005.03.019. 183. De Bonis M, Reynolds L, Barros J, Madden BP. Tacrolimus as a rescue immunosuppressant after heart transplantation. Eur J Cardiothorac Surg. 2001;19(5):690-5. PMID: 11343954. 184. Barr ML, Meiser BM, Eisen HJ, Roberts RF, Livi U, Dall’Amico R, et al. Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med. 1998;339:1744-1751. doi: 10.1056/ NEJM199812103392404 185. Tan CD, Sokos GG, Pidwell DJ, Smedira NG, Gonzalez-Stawinski GV, Taylor DO, et al. Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant. 2009;9(9):2075-84. doi: 10.1111/j.1600- 6143.2009.02748.x. 186. Berry GJ, Angelini A, Burke MM, Bruneval P, Fishbein MC, Hammond E, et al. The ISHLTworking formulation for pathologic diagnosis of antibody- mediated rejection in heart transplantation: evolution and current status (2005-2011). JHeartLungTransplant.2011;30(6):601-11.doi:10.1016/j. healun.2011.02.015. 187. Hammond ME, Revelo MP, Miller DV, Snow GL, Budge D, Stehlik J, et al. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: a retrospective validation analysis. J Heart Lung Transplant. 2016;35(3):320-5. doi: 10.1016/j. healun.2015.10.035. 188. Faulk WP, Rose M, Meroni PL, Del Papa N, Torry RJ, Labarrere CA, et al. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol. 1999;60(9):826-32. PMID: 10527389. 189. Nath DS, Ilias Basha H, Tiriveedhi V, Alur C, Phelan D, Ewald GA, et al. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy. J Heart Lung Transplant. 2010;29(11):1277-85. doi: 10.1016/j.healun.2010.05.025. 190. ReinsmoenNL. Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation. Hum Immunol. 2013;74(11):1474-7. doi: 10.1016/j.humimm.2013.06.034. 191. Wang SS, Chou NK, Ko WJ, Chi NH, Hung SC, Hsu RB, et al. Effect of plasmapheresis for acute humoral rejection after heart transplantation. Transplant Proc. 2006;38(10):3692-4. doi: 10.1016/j. transproceed.2006.10.060. 286